Tarianna V. Stewart, Ph.D.


Tarianna Stewart heads the firm’s client development initiative and is a Technical Advisor in the areas of biotechnology, nanotechnology and neurophysiology principles.  Tarianna also assists in patent drafting, prosecution and docket management.


Prior to joining Smith Tempel, Tarianna gained extensive technical expertise through her undergraduate and graduate studies in the fields of neuroscience, neurobiology, neuropharmacology, biology, molecular biology, molecular genetics, immunology and biochemistry.  She received her Bachelor of Science in Psychology and her Master of Biology from Georgia State University in 2007 and 2009, respectively.  She earned her Ph.D. in the field of Biomedical Science from Morehouse School of Medicine in 2017.

During her academic studies, Tarianna held positions with Emory University School of Medicine as a research assistant and senior research project coordinator.  In these capacities, she gained extensive technical experience in numerous areas of psychiatry including clinical research of schizophrenia.  During her Ph.D. program, she also worked in conjunction with the Kimberly Clark corporation and Emory’s School of Medicine to study the regulation of epithelial cellular pathways by nanostructured thin films, an effort that included development of an in vitro model to determine the extent that nanostructured thin films may enhance the transepithelial transport of agents in a substrate dependent manner utilizing both the transcellular and paracellular routes.  She has published and presented her research in this use of nanostructured thin films at many conferences and forums around the United States.


Morehouse School of Medicine, Ph.D. Biomedical Science, 2017

Georgia State University, M.S. Biology, 2009.

Georgia State University, B.S. Psychology, 2007.


Selected Publications 

Stewart T, Koval WT, Molina SA, Bock SM, Lillard JW Jr, Ross RF, Desai TA, Koval M.(2017) Calibrated flux measurements reveal a nanostructure-stimulated transcytotic pathway.  Experimental Cell Research 355(2):153-161. 

Ramsay CE, Stewart T, Compton MT. (2012) Unemployment among patients with first-episode psychosis: prevalence and clinical correlates in a U.S. sample. Social Psychiatry and Psychiatric Epidemiology 47:797-803.

Compton MT, Broussard B, Ramsay CE, Stewart T (2011) Pre-Illness Cannabis Use and the Early Course of Nonaffective Psychotic Disorders: Associations with Premorbid Functioning, the Prodrome, and Mode of Onset of Psychosis. Schizophrenia Research; 126: 71-76

Stewart T, Goulding SM, Pringle M, Esterberg ML, Compton MT (2010) A descriptive study of nicotine, alcohol, and cannabis use in urban, socially-disadvantaged, predominantly African American patients with first-episode nonaffective psychosis. Clinical Schizophrenia and Related Psychosis; 3:217-225

Compton MT, Kelley ME, Ramsay CE, Pringle M, Goulding SM, Esterberg ML, Stewart T, Walker EF (2009) Relation of pre-onset cannabis, alcohol, and tobacco use with the age at onset of prodrome and age at onset of psychosis in first-episode patients. American Journal of Psychiatry; 166: 1251-1257

Compton MT, Carter T, Bergner E, Franz L, Stewart T, Trotman H, McGlashan TH, McGorry PD (2007) Defining, operationalizing, and measuring the duration of untreated psychosis (DUP): Advances, limitations, and future directions. Early Intervention in Psychiatry; 1: 236-250